Research Study

Nobiletin and Eriodictyol Suppress Release of IL-1β, CXCL8, IL-6, and MMP-9 from LPS, SARS-CoV-2 Spike Protein, and Ochratoxin A-Stimulated Human Microglia.

📅 2025 🔗 DOI: 10.3390/ijms26020636

Citation

Tsilioni I., Kempuraj D., Theoharides T. (2025). Nobiletin and Eriodictyol Suppress Release of IL-1β, CXCL8, IL-6, and MMP-9 from LPS, SARS-CoV-2 Spike Protein, and Ochratoxin A-Stimulated Human Microglia.. Int J Mol Sci. DOI: 10.3390/ijms26020636

View Full Study →

Abstract

Abstract not available. See citation for source.

Disclaimer: This research summary is for educational purposes only. Always consult with a healthcare professional before making decisions based on scientific research.

Nobiletin and Eriodictyol Suppress Release of IL-1&#x3b2;, CXCL8, IL-6, and MMP-9 from LPS, SARS-CoV-2 Spike Protein, and Ochratoxin A-Stimulated Human Microglia.

Abstract

Related Substances

Nobiletin and Eriodictyol Suppress Release of IL-1β, CXCL8, IL-6, and MMP-9 from LPS, SARS-CoV-2 Spike Protein, and Ochratoxin A-Stimulated Human Microglia.